Prosecution Insights
Last updated: August 06, 2026

Mchale & Slavin, P.A.

27 pending office actions • 20 clients • 26 examiners • 22 art units • 0 of 27 (0%) have an AI response strategy ready

Quality Metrics (n=10541 apps, methodology: how we score firms)

87.2%
Allowance Rate
n=10541
+0.54σ
Allowance Rate (norm)
n=10541
2.9
OAs to Allowance
n=7273
-0.32σ
OAs to Allow (norm)
n=7273
943 days
Time to Allowance
n=7273
+8.8pp
Interview Lift
n=10541
19.9%
RCE Rate
n=10541
2.4%
Appeal Rate
n=10541

Rejection Performance (% of received rejections ultimately overcome)

82.0%
§101 Overcome
n=637
82.7%
§102 Overcome
n=2935
83.3%
§103 Overcome
n=4583
84.7%
§112 Overcome
n=3288

Specialization & Scale

F01D, F05D, H10D
Top CPC Subclasses
12%
Top-3 CPC Share
n=10541
8
Practitioners
n=10541
1317.6
Apps / Practitioner
n=10541

Portfolio Summary

27
Total Pending OAs
12
Non-Final OAs
13
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
1
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 7 days (1)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (41%)
11
Medium (41%)
5
Easy (19%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (7%)
§103 only9 (33%)
§102 only2 (7%)
§112 only4 (15%)
Double-patenting only1 (4%)
Multi-statute (no §101)9 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
41% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
2
Semiconductors
7% of docket
11
Mechanical / Eng
41% of docket
2
Business / Other
7% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

270 h
Manual time on pending OAs
54 h
Time saved (low, 20%)
94 h
Time saved (mid, 35%)
2.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZEMAN, ROBERT A 2 54.0% +27.9%
PRESSLEY, PAUL DEREK 1 62.0% +25.3%
LYNCH, CARLY W 1 50.8% +48.1%
KAMIKAWA, TRACY L 1 58.7% +37.4%
GANGLE, BRIAN J 1 76.7% +15.0%
NOBREGA, TATIANA L 1 33.2% +59.0%
LEE, MICHAEL S 1 63.4% +20.9%
MCCALISTER, WILLIAM M 1 69.1% +19.4%
MATTHEWS, TESSA M 1 83.3% +24.4%
DOWNING, SAVANNAH STARR 1 78.6% +4.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18742374 PLIF SPACER MATTHEWS, TESSA M

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17642335 Method for identifying T-cell epitopes SKIBINSKY, ANNA 8d overdue
17786631 Nucleic acid vaccination using neo-epitope encoding constructs LI, BAO Q 3d overdue
18041244 Autologous, prevascularized breast tissue constructs produced in a 3D printing method, and methods for producing same SINGH, ANOOP KUMAR 84d
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD KAMIKAWA, TRACY L
18771483 HAIR EXTENSION NOBREGA, TATIANA L
18769286 SLIDE FASTENER CHAIN LINK LEE, MICHAEL S
18732821 Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosa ZEMAN, ROBERT A
18731788 CAVITY IONIZATION CHAMBER FOR MEASURING DOSE RATE AT PROTECTION-LEVEL DOWNING, SAVANNAH STARR

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19220053 SYSTEM AND METHOD FOR PLANT AGRICULTURE LYNCH, CARLY W 15d overdue
19350725 APPARATUS FOR DESTROYING ELECTRONIC DATA AND PROVIDING SELECTIVE STORAGE PRESSLEY, PAUL DEREK 3d overdue
18479501 PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS ZEMAN, ROBERT A 12d
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD KAMIKAWA, TRACY L
18999335 Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae GANGLE, BRIAN J
18771483 HAIR EXTENSION NOBREGA, TATIANA L
18769286 SLIDE FASTENER CHAIN LINK LEE, MICHAEL S
18763315 Six bolt carburetor float bowl housing securement MCCALISTER, WILLIAM M

Client Portfolio (20 clients)

Top Art Units

Art UnitApps
37733
16452
37251
36431
37751
37991
36771
28381
28341
17541

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19350725 APPARATUS FOR DESTROYING ELECTRONIC DATA AND PROVIDING SELECTIVE STORAGE Phiston Technologies, Inc. PRESSLEY, PAUL DEREK 3725 §103 Non-Final OA 3d overdue Pending Oct 06, 2025
19220053 SYSTEM AND METHOD FOR PLANT AGRICULTURE Jardin Holdings I, LLC LYNCH, CARLY W 3643 §103 Final Rejection 15d overdue Pending May 27, 2025
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD Marc J. Levine KAMIKAWA, TRACY L 3775 §102§103§112 Non-Final OA Pending Jan 28, 2025
18999335 Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae Evaxion Biotech A/S GANGLE, BRIAN J §112 Non-Final OA Pending Dec 23, 2024
18771483 HAIR EXTENSION New Image Labs Corporation NOBREGA, TATIANA L 3799 §101§103 Final Rejection Pending Jul 12, 2024
18769286 SLIDE FASTENER CHAIN LINK Shah Technologies LLC LEE, MICHAEL S 3677 §103§112 Final Rejection Pending Jul 10, 2024
18763315 Six bolt carburetor float bowl housing securement Weaver Intellectual Property, LLC MCCALISTER, WILLIAM M §112 Non-Final OA Pending Jul 03, 2024
18742374 PLIF SPACER Atlas Spine, Inc. MATTHEWS, TESSA M 3773 §102 Final Rejection Pending Jun 13, 2024
18732821 Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosa Evaxion Biotech A/S ZEMAN, ROBERT A 1645 §102§103§112 Non-Final OA Pending Jun 04, 2024
18731788 CAVITY IONIZATION CHAMBER FOR MEASURING DOSE RATE AT PROTECTION-LEVEL National Institute Of Metrology, China DOWNING, SAVANNAH STARR 2838 §103§112 Non-Final OA Pending Jun 03, 2024
18731106 POWER GENERATOR Mountain N Meadow Holdings, Inc. ALMAWRI, MAGED M 2834 §102§103§112 Non-Final OA Pending May 31, 2024
18634385 Floor plank modification system Newgen Enterprises, LLC YE, XINWEN 1754 §103 Final Rejection Pending Apr 12, 2024
18598732 MINIMALLY INVASIVE SURGERY ADD ON SCREW SYSTEM Snj Patents, LLC GREEN, MICHELLE CHRISTINE 3773 §102§103§112Other Non-Final OA Pending Mar 07, 2024
18556171 Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts BIONEXT LABS LTD RONEY, CELESTE A 1612 §112 Non-Final OA Pending Oct 19, 2023
18479501 PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS Evaxion Biotech A/S ZEMAN, ROBERT A 1645 §102 Non-Final OA 12d Pending Oct 02, 2023
18368839 STORAGE SHED Suncast Technologies, LLC BARLOW, ADAM G 3633 §103 Final Rejection Pending Sep 15, 2023
18346400 STORAGE SAFE WITH REMOTE PALM READER Hornady Manufacturing Company GILES, EBONI N 2622 §103 Non-Final OA 33d Pending Jul 03, 2023
18342847 BEVERAGE SERVICE STATION AND BAR Suncast Technologies, LLC WILKENS, JANET MARIE 3637 §103§112 Final Rejection Pending Jun 28, 2023
18326336 Expandable and contractible garden hose Telebrands Corp. ZOLLINGER, NATHAN C 3746 §103Other Final Rejection Pending May 31, 2023
18254456 A method and a system for filtering a suspension Chreto Aps BULLOCK, IN SUK C 1772 §103 Final Rejection Pending May 25, 2023
18251818 Microfluidic flow cell and system for analyzing or diagnosing biofilms and cell cultures, and the use thereof Johannes Gutenberg-Universität Mainz KWAK, DEAN P 1798 §103 Final Rejection 5d Pending May 04, 2023
18177038 INTERVERTEBRAL DEVICES AND RELATED METHODS Expanding Innovations, Inc. PLIONIS, NICHOLAS J 3773 §103 Final Rejection Pending Mar 01, 2023
18041244 Autologous, prevascularized breast tissue constructs produced in a 3D printing method, and methods for producing same UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ SINGH, ANOOP KUMAR 1632 §103§112 Non-Final OA 84d Pending Feb 10, 2023
17995601 Neoepitope immunotherapy with APC targeting unit Evaxion Biotech A/S DENT, ALANA HARRIS 1643 DP Final Rejection Pending Oct 06, 2022
17786631 Nucleic acid vaccination using neo-epitope encoding constructs Evaxion Biotech A/S LI, BAO Q 1671 §103§112 Final Rejection 3d overdue Pending Jun 17, 2022
17642335 Method for identifying T-cell epitopes Evaxion Biotech A/S SKIBINSKY, ANNA 1635 §101§103§112 Non-Final OA 8d overdue Pending Mar 11, 2022
16970688 Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ MCCOLLUM, ANDREA K 1674 §112 Non-Final OA 99d overdue Pending Aug 18, 2020

Managing Mchale & Slavin, P.A.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month